“The unimaginableness of most objects,by reason of their smallness”

R. Hooke, London, 1665

 

Susan-01_edited.jpg
_edited_edited.jpg

ABOUT US

We develop microfluidic based technologies for  high throughput drug screening in conjunction with 3-D cell culture. This technology is adaptable to a multitude of applications such as: disease modelling, drug discovery, drug re-purposing, toxicity testing of chemicals, microbial screening and personalized drug optimization. . .

Prof Mark Davies

Executive Chair & Founder

Executive Team

Dr Mark Lyons

Chief Executive Officer

Dr Finola Cliffe

Chief Operations Offier

Awards

Supported by

 

Email:   info@hookebio.com

Phone:  0860448422

Hooke Bio

L4A Smithstown Industrial Estate

Shannon

Co. Clare

V14XH92